S&P 500   5,052.45 (-0.19%)
DOW   37,806.91 (+0.19%)
QQQ   430.55 (-0.12%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
S&P 500   5,052.45 (-0.19%)
DOW   37,806.91 (+0.19%)
QQQ   430.55 (-0.12%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
S&P 500   5,052.45 (-0.19%)
DOW   37,806.91 (+0.19%)
QQQ   430.55 (-0.12%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
S&P 500   5,052.45 (-0.19%)
DOW   37,806.91 (+0.19%)
QQQ   430.55 (-0.12%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
Free Trial

AcelRx Pharmaceuticals (ACRX) News Today

→ AI “wealth window” is closing soon! (From Paradigm Press) (Ad)
Free ACRX Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability
SourceHeadline
markets.businessinsider.com logoTalphera’s Strategic Rebrand and Niyad’s Market Potential Bolster Buy Rating
markets.businessinsider.com - January 11 at 3:37 PM
msn.com logoAcelRx announces rebranding with name change to Talphera
msn.com - January 9 at 10:31 AM
finance.yahoo.com logoAcelRx Announces Rebranding With Name Change to Talphera, Inc.
finance.yahoo.com - January 9 at 10:31 AM
benzinga.com logoAcelRx Pharmaceuticals Stock (NASDAQ:ACRX) Dividends: History, Yield and Dates
benzinga.com - December 22 at 6:12 PM
finance.yahoo.com logoAcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States
finance.yahoo.com - December 12 at 9:00 AM
msn.com logoAcelRx Pharmaceuticals files for $150M mixed shelf
msn.com - November 22 at 6:03 PM
finanznachrichten.de logoAcelRx Pharmaceuticals, Inc.: AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - November 9 at 10:48 AM
msn.com logoAcelRx Pharmaceuticals Q3 2023 Earnings Preview
msn.com - November 7 at 10:18 PM
finance.yahoo.com logoAcelRx to Host KOL Panel Discussion on Current Anticoagulant Use in Dialysis and the Upcoming Niyad™ Clinical Study
finance.yahoo.com - November 7 at 5:17 PM
finance.yahoo.com logoAcelRx to Host Third Quarter 2023 Financial Results Call and Webcast on November 8, 2023
finance.yahoo.com - October 26 at 7:53 PM
finance.yahoo.com logoAcelRx Receives IDE Approval for Niyad and Advances to a Single Registration Study
finance.yahoo.com - October 3 at 9:51 AM
msn.com logoAcelRx CEO buys 10,000 shares
msn.com - September 12 at 5:37 PM
finance.yahoo.com logoInsider Buying: CEO Vincent Angotti Acquires 10,000 Shares of AcelRx Pharmaceuticals Inc
finance.yahoo.com - September 12 at 5:37 PM
finance.yahoo.com logoWhat Makes AcelRx Pharmaceuticals (ACRX) a New Buy Stock
finance.yahoo.com - August 22 at 11:54 PM
markets.businessinsider.com logoPositive Report for Acelrx (ACRX) from H.C. Wainwright
markets.businessinsider.com - August 18 at 7:06 AM
finance.yahoo.com logoAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q2 2023 Earnings Call Transcript
finance.yahoo.com - August 13 at 6:53 AM
finanznachrichten.de logoAcelRx Pharmaceuticals, Inc.: AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - August 12 at 12:51 AM
finance.yahoo.com logoQ2 2023 AcelRx Pharmaceuticals Inc Earnings Call
finance.yahoo.com - August 11 at 7:50 PM
finance.yahoo.com logoAcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - August 11 at 3:05 AM
finance.yahoo.com logoAcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 11 at 3:05 AM
finance.yahoo.com logoAcelRx to Host Second Quarter 2023 Financial Results Call and Webcast on August 10, 2023
finance.yahoo.com - July 28 at 10:16 AM
finance.yahoo.com logoAcelRx Pharmaceuticals Announces Closing of Previously Announced Private Placement Priced At-The-Market Under Nasdaq Rules
finance.yahoo.com - July 21 at 8:53 AM
seekingalpha.com logoAcelRx Pharmaceuticals launches ~$10M private placement of shares
seekingalpha.com - July 18 at 9:51 AM
finance.yahoo.com logoAcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
finance.yahoo.com - July 18 at 9:51 AM
finance.yahoo.com logoACRX - AcelRx Pharmaceuticals, Inc.
finance.yahoo.com - June 17 at 8:16 PM
fool.com logoAcelRx Pharmaceuticals (NASDAQ: ACRX)
fool.com - June 16 at 5:46 PM
finanznachrichten.de logoAcelRx Pharmaceuticals, Inc.: AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - May 13 at 6:18 AM
msn.com logoRecap: AcelRx Pharmaceuticals Q1 Earnings
msn.com - May 11 at 10:29 PM
finance.yahoo.com logoAcelRx Pharmaceuticals (ACRX) Reports Break-Even Earnings for Q1
finance.yahoo.com - May 10 at 9:28 PM
finance.yahoo.com logoAcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - May 10 at 4:27 PM
finance.yahoo.com logoEarnings Preview: Crinetics Pharmaceuticals, Inc. (CRNX) Q1 Earnings Expected to Decline
finance.yahoo.com - May 4 at 1:29 PM
msn.com logoAcelRx Pharmaceuticals (ACRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
msn.com - May 3 at 12:27 PM
finance.yahoo.com logoAcelRx to Host First Quarter 2023 Financial Results Call and Webcast on May 10, 2023
finance.yahoo.com - April 27 at 7:24 PM
finance.yahoo.com logoAcelRx Pharmaceuticals Announces Closing of Divestment of DSUVIA® to Alora Pharmaceuticals
finance.yahoo.com - April 5 at 9:38 AM
finance.yahoo.com logoAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q4 2022 Earnings Call Transcript
finance.yahoo.com - April 4 at 2:20 PM
finanznachrichten.de logoAcelRx Pharmaceuticals, Inc.: AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update
finanznachrichten.de - March 31 at 10:33 AM
markets.businessinsider.com logoAcelrx (ACRX) Receives a Hold from H.C. Wainwright
markets.businessinsider.com - March 31 at 10:33 AM
finance.yahoo.com logoAcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - March 30 at 6:44 PM
msn.com logoEarnings Outlook For AcelRx Pharmaceuticals
msn.com - March 29 at 5:42 PM
finance.yahoo.com logoAcelRx to Host Full Year and Fourth Quarter 2022 Financial Results Call and Webcast on March 30, 2023
finance.yahoo.com - March 21 at 5:29 PM
marketwatch.com logoAcelRx Pharmaceuticals Shares Rise Premarket on Dsuvia Sale >ACRX
marketwatch.com - March 14 at 6:55 PM
msn.com logoAcelRx adds 16% on plans to divest pain therapy
msn.com - March 14 at 6:55 PM
finance.yahoo.com logoAcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora Pharmaceuticals
finance.yahoo.com - March 14 at 6:55 PM
thestreet.com logoHere's Why AcelRx Pharmaceuticals (ACRX) Stock Gained Today
thestreet.com - February 24 at 7:56 AM
forbes.com logoAcelrx Pharmaceuticals
forbes.com - January 18 at 11:46 PM
finance.yahoo.com logoAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q3 2022 Earnings Call Transcript
finance.yahoo.com - December 29 at 8:24 AM
finance.yahoo.com logoAcelRx Announces $7.5 Million Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock
finance.yahoo.com - December 27 at 1:32 PM
marketbeat.com logoThree Healthcare Penny Stocks to Watch In The New Year
marketbeat.com - December 27 at 1:00 AM
marketbeat.com logoThree Healthcare Penny Stocks to Watch In The New Year (ACRX)
marketbeat.com - December 26 at 8:37 PM
benzinga.com logoLooking Into AcelRx Pharmaceuticals's Return On Capital Employed
benzinga.com - December 26 at 1:38 PM
Get AcelRx Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACRX and its competitors with MarketBeat's FREE daily newsletter.

Can't believe it's happening again (Ad)

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

ACRX Media Mentions By Week

ACRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACRX
News Sentiment
▼
0.00

0.66
▲
Average
Medical
News Sentiment

ACRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACRX Articles
This Week
▼
0

0
▲
ACRX Articles
Average Week

Get AcelRx Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:ACRX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Can't believe it's happening again
Manward Press
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Options trading has suddenly become more reliable.
Eagle Publishing
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press